CDTX - Cidara Therapeutics GAAP EPS of -$0.09 beats by $0.06 revenue of $12.72M beats by $4.58M
2023-11-02 17:40:32 ET
More on Cidara Therapeutics
- Cidara Therapeutics: Reduced Risk Due To Janssen's Decision And Progress In The Oncology Pipeline
- Buy Cidara Therapeutics For The Cloudbreak Platform
- Cidara Therapeutics: Leveraging Antifungals To Move Into Cancer Therapy
- Seeking Alpha’s Quant Rating on Cidara Therapeutics
- Historical earnings data for Cidara Therapeutics
For further details see:
Cidara Therapeutics GAAP EPS of -$0.09 beats by $0.06, revenue of $12.72M beats by $4.58M